arrow
N

Nicolette F. de Keizer

national intensive care evaluation foundation
H指数:63
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Causality assessment tool for drug-induced acute kidney injury in patients admitted to intensive care units: Requirements from a multicentre retrospective study in the Netherlands reusing data from electronic health records

重症监护病房患者药物诱导急性肾损伤的因果关系评估工具:来自荷兰一项多中心回顾性研究的电子健康记录数据再利用需求

2026-09-160
OAAI
Between-centre variation in antibiotic therapeutic drug monitoring and obtaining surveillance cultures in Dutch ICUs: A retrospective observational study

荷兰ICU中抗生素治疗药物监测和获取监测培养物的中心间变异:一项回顾性观察性研究

2026-03-140
OAAI
COVID-19 Vaccine Effectiveness in Patients With Hematologic Malignancies: A Nationwide Cohort Study

COVID-19疫苗在血液系统恶性肿瘤患者中的有效性:一项全国性队列研究

2025-10-010
OAAI
The authors reply:

作者回复:

2025-08-050
PRE
Using the Observational Medical Outcomes Partnership Common Data Model for a multi-registry intensive care unit benchmarking federated analysis: lessons learned

使用观察性医疗结果合作伙伴关系通用数据模型进行多注册重症监护病房基准联邦分析:经验教训

2025-08-010
PRE
The authors reply:

作者回复:

2025-07-010
PRE
Towards robust real-time surveillance of severe acute respiratory infections: Exploring the potential of an existing national intensive care unit registry

向重症急性呼吸道感染稳健的实时监测:探索现有国家重症监护病房登记系统的潜力

2025-06-100
OA
Clinical phenotyping uncovers heterogeneous associations between corticosteroid treatment and survival in critically ill COVID-19 patients
2024-08-261
OAAI
Prevalence of frailty and association with patient centered outcomes: A prospective registry-embedded cohort study from India
2024-04-014
OAAI
The effect of computerised decision support alerts tailored to intensive care on the administration of high-risk drug combinations, and their monitoring: a cluster randomised stepped-wedge trial
LANCET
IF88.5
2024-02-019
OAAI